SI-BONE, Inc. (SIBN)
After hours:
| Previous close | 15.54 |
| Open | 15.59 |
| Bid | 15.26 x 100 |
| Ask | 15.35 x 100 |
| Day's range | 15.16 - 15.76 |
| 52-week range | 13.96 - 29.51 |
| Volume | |
| Avg. volume | 464,867 |
| Market cap | 631.67M |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.08 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.56 |
Simply Wall St.Here's What Analysts Are Forecasting For SI-BONE, Inc. (NASDAQ:SIBN) After Its First-Quarter Results
SI-BONE, Inc. ( NASDAQ:SIBN ) just released its latest first-quarter results and things are looking bullish. Results...
Insider MonkeySI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript May 6, 2024 SI-BONE, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to SI-Bone First Quarter 2024 Earnings Conference Call. At this time, all participants are in […]
GlobeNewswireSI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the first cases completed with the smaller, 9.5 mm diameter, iFuse Bedrock Granite® Implant (Granite 9.5). When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion. This mileston
